{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:48:22Z","timestamp":1770346102708,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1093\/jac\/44.4.501","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:24:55Z","timestamp":1027722295000},"page":"501-513","source":"Crossref","is-referenced-by-count":130,"title":["Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis"],"prefix":"10.1093","volume":"44","author":[{"given":"Robert","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Kubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Ballin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Matthias","family":"Deppermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry P.","family":"Bassaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Leophonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad J. M.","family":"Schreurs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Sommerauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,10]]},"reference":[{"key":"key\n\t\t\t\t20170411034535_R1","unstructured":"American Thoracic Society. (1995). Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine152, Suppl. , S77\u2013121."},{"key":"key\n\t\t\t\t20170411034535_R2","doi-asserted-by":"crossref","unstructured":"Wilson, R., Tillotson, G. & Ball, P. (1996). Clinical studies in chronic bronchitis: a need for better definition and classification of severity. Journal of Antimicrobial Chemotherapy37, 205\u20138.","DOI":"10.1093\/jac\/37.2.205"},{"key":"key\n\t\t\t\t20170411034535_R3","unstructured":"Chodosh, S. (1990). Quinolones in acute bacterial exacerbations of chronic bronchitis. In The New Generation of Quinolones (Siporin, C., Heifetz, C. L. & Domagala, J. M., Eds), pp. 249\u201376. Marcel Dekker, Inc., New York, NY."},{"key":"key\n\t\t\t\t20170411034535_R4","doi-asserted-by":"crossref","unstructured":"Anthonisen, N. R., Manfreda, J., Warren, C. P. W., Hershfield, E. S., Harding, G. K. & Nelson, N. A. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine106, 196\u2013204.","DOI":"10.7326\/0003-4819-106-2-196"},{"key":"key\n\t\t\t\t20170411034535_R5","doi-asserted-by":"crossref","unstructured":"Saint, S., Bent, S., Vittinghoff, E. & Grady, D. (1995). Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. Journal of the American Medical Association273, 957\u201360.","DOI":"10.1001\/jama.1995.03520360071042"},{"key":"key\n\t\t\t\t20170411034535_R6","doi-asserted-by":"crossref","unstructured":"Felmingham, D. & Gr\u00fcneberg, R. N. (1996). A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992\u20131993: the Alexander Project. Journal of Antimicrobial Chemotherapy38, Suppl. A, 1\u201357.","DOI":"10.1093\/jac\/38.suppl_A.1"},{"key":"key\n\t\t\t\t20170411034535_R7","doi-asserted-by":"crossref","unstructured":"Thornsberry, C., Ogilvie, P., Kahn, J. & Mauriz, Y. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996\u20131997 respiratory season. The Laboratory Investigator Group. Diagnostics in Microbiology and Infectious Disease29, 249\u201357.","DOI":"10.1016\/S0732-8893(97)00195-8"},{"key":"key\n\t\t\t\t20170411034535_R8","doi-asserted-by":"crossref","unstructured":"Friedland, I. R. & McCracken, G. H. (1994). Management of infections caused by antibiotic resistant Streptococcus pneumoniae. New England Journal of Medicine331, 377\u201382.","DOI":"10.1056\/NEJM199408113310607"},{"key":"key\n\t\t\t\t20170411034535_R9","doi-asserted-by":"crossref","unstructured":"Latorre, C., Juncosa, T. & Sanfeliu, I. (1985). Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain. Antimicrobial Agents and Chemotherapy28, 357\u20139.","DOI":"10.1128\/AAC.28.2.357"},{"key":"key\n\t\t\t\t20170411034535_R10","doi-asserted-by":"crossref","unstructured":"Marton, A., Gulyas, M., Munoz, R. & Tomasz, A. (1991). Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. Journal of Infectious Diseases163, 542\u20138.","DOI":"10.1093\/infdis\/163.3.542"},{"key":"key\n\t\t\t\t20170411034535_R11","doi-asserted-by":"crossref","unstructured":"Reinert, R. R., Queck, A., Kaufhold, A., Kresken, M. & L\u00fctticken, R. (1995). Antimicrobial resistance and type distribution of Streptococus pneumoniae isolates causing systemic infections in Germany, 1992\u20131994. Clinical Infectious Diseases21, 1398\u2013401.","DOI":"10.1093\/clinids\/21.6.1398"},{"key":"key\n\t\t\t\t20170411034535_R12","doi-asserted-by":"crossref","unstructured":"Felmingham, D., Robbins, M. J., Tesfaslasie, Y., Harding, I., Shrimpton, S. & Gr\u00fcneberg, R. N. (1998). Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995\u20131996 cold season. Journal of Antimicrobial Chemotherapy41, \u20135.","DOI":"10.1093\/jac\/41.3.411"},{"key":"key\n\t\t\t\t20170411034535_R13","doi-asserted-by":"crossref","unstructured":"Wise, R. & Andrews, J. M. (1998). Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group. Lancet352, 657\u20138.","DOI":"10.1016\/S0140-6736(05)79618-5"},{"key":"key\n\t\t\t\t20170411034535_R14","doi-asserted-by":"crossref","unstructured":"Mason, E. O. & Kaplan, S. L. (1995). Penicillin-resistant pneumococci in the United States. Pediatric Infectious Disease Journal14, 1017\u20138.","DOI":"10.1097\/00006454-199511000-00026"},{"key":"key\n\t\t\t\t20170411034535_R15","doi-asserted-by":"crossref","unstructured":"Felmingham, D., Robbins, M. J., Dencer, C., Nathwani, A. & Gr\u00fcneberg, R. N. (1996). Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens. Journal of Antimicrobial Chemotherapy38, 747\u2013 51.","DOI":"10.1093\/jac\/38.4.747"},{"key":"key\n\t\t\t\t20170411034535_R16","doi-asserted-by":"crossref","unstructured":"Dalhoff, A., Petersen, U. & Endermann, R. (1996). In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy42, 410\u201325.","DOI":"10.1159\/000239474"},{"key":"key\n\t\t\t\t20170411034535_R17","doi-asserted-by":"crossref","unstructured":"MacGowan, A. P., Bowker, K. E., Holt, H. A., Wootton, M. & Reeves, D. S. (1997). BAY 12-8039, a new 8-methoxy-quinolone:comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. Journal of Antimicrobial Chemotherapy40 , 503\u20139.","DOI":"10.1093\/jac\/40.4.503"},{"key":"key\n\t\t\t\t20170411034535_R18","doi-asserted-by":"crossref","unstructured":"Woodcock, J. M., Andrews, J. M., Boswell, F. J., Brenwald, N. P. & Wise, R. (1997). In vitroactivity of BAY 12-8039, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy41 , 101\u20136.","DOI":"10.1128\/AAC.41.1.101"},{"key":"key\n\t\t\t\t20170411034535_R19","unstructured":"Robson, H. G., Tremblay, J.-F., Loo, V. G., Lavallee, J. & McAlear, D. (1997). Comparative in-vitro activity of trovafloxacin, BAY 12-8039 and clinafloxacin against penicillin-intermediate and -resistant Streptococcus pneumoniae. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract F135, p. 169. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411034535_R20","doi-asserted-by":"crossref","unstructured":"Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1997). Antineumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral \u03b2-lactams. Antimicrobial Agents and Chemotherapy41, 2786\u20139.","DOI":"10.1128\/AAC.41.12.2786"},{"key":"key\n\t\t\t\t20170411034535_R21","doi-asserted-by":"crossref","unstructured":"Stass, H., Dalhoff, A., Kubitza, D. & Sch\u00fchly, U. (1998) Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxyquinolone, administered to healthy subjects. Antimicrobial Agents and Chemotherapy42, 2060\u2013 5.","DOI":"10.1128\/AAC.42.8.2060"},{"key":"key\n\t\t\t\t20170411034535_R22","unstructured":"Andrews, J., Honeybourne, D., Jevons, G. & Wise, R. (1998). Penetration of moxifloxacin into bronchial mucosa, epithelial lining fluid and alveolar macrophages following a single 400 mg oral dose. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, USA, 1998. Abstract A29, p. 9. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411034535_R23","doi-asserted-by":"crossref","unstructured":"Siafakas, N. M., Vermeire, P., Pride, N. B., Paoletti, P., Gibson, J., Howard, P. et al. (1995). Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. European Respiratory Journal8, 1398\u2013420.","DOI":"10.1183\/09031936.95.08081398"},{"key":"key\n\t\t\t\t20170411034535_R24","doi-asserted-by":"crossref","unstructured":"Appelbaum, P. C. (1996). Epidemiology and in vitrosusceptibility of drug-resistant Streptococcus pneumoniae. Pediatric Infectious Disease Journal15, 932\u20134.","DOI":"10.1097\/00006454-199610000-00030"},{"key":"key\n\t\t\t\t20170411034535_R25","doi-asserted-by":"crossref","unstructured":"Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy40, 1208\u201313.","DOI":"10.1128\/AAC.40.5.1208"},{"key":"key\n\t\t\t\t20170411034535_R26","doi-asserted-by":"crossref","unstructured":"Cazzola, M., Vinciguerra, A., Beghi, G. F., Paizis, G., Giura, R., Madonini, V. et al. (1995). Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav versus cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. Journal of Chemotherapy7 , 432\u201341.","DOI":"10.1179\/joc.1995.7.5.432"},{"key":"key\n\t\t\t\t20170411034535_R27","doi-asserted-by":"crossref","unstructured":"Chodosh S., Lakshminarayan, S., Swarz, H. & Breisch, S. (1998). Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily. Antimicrobial Agents and Chemotherapy42, 114\u201320.","DOI":"10.1128\/AAC.42.1.114"},{"key":"key\n\t\t\t\t20170411034535_R28","doi-asserted-by":"crossref","unstructured":"Periti, P., Novelli, A., Schildwachter, G., Schmidt-Gayk, H., Ryo, Y. & Zuck, P. (1990). Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy26, Suppl. E, 63\u20139.","DOI":"10.1093\/jac\/26.suppl_E.63"},{"key":"key\n\t\t\t\t20170411034535_R29","doi-asserted-by":"crossref","unstructured":"Rademaker, C. M. A., Sips, A. P., Beumer, H. M., Hoepelman, I. M., Overbeek, B. P., M\u00f6llers, M. J. et al. (1990). A double-blind comparison of low-dose ofloxacin and amoxycillin-clavulanic acid in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy26, Suppl. D, 75\u201381.","DOI":"10.1093\/jac\/26.suppl_D.75"},{"key":"key\n\t\t\t\t20170411034535_R30","doi-asserted-by":"crossref","unstructured":"Ziering, W. & McElvaine, P. (1998). Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbations of chronic bronchitis. Infection26, 68\u201375.","DOI":"10.1007\/BF02768764"},{"key":"key\n\t\t\t\t20170411034535_R31","unstructured":"Ball, P., Harris, J. M., Lowson, D., Tillotson, G. & Wilson, R. (1995). Acute infective exacerbations of chronic bronchitis. Quarterly Journal of Medicine88, 61\u2013 8."},{"key":"key\n\t\t\t\t20170411034535_R32","doi-asserted-by":"crossref","unstructured":"Wilson, R. (1995). Outcome predictors in bronchitis. Chest108, Suppl., 53S\u20137S.","DOI":"10.1378\/chest.108.2_Supplement.53S"},{"key":"key\n\t\t\t\t20170411034535_R33","doi-asserted-by":"crossref","unstructured":"Sufarlan, A. W., Zainudin, B. M. Z., Pit, S. & Ishak, I. (1995). Causative organisms in acute exacerbation of chronic airways disease and response to ofloxacin therapy. Drugs 49, Suppl. 2, 442\u20135.","DOI":"10.2165\/00003495-199500492-00129"},{"key":"key\n\t\t\t\t20170411034535_R34","doi-asserted-by":"crossref","unstructured":"Langan, C., Clecner, B., Cazzola, C. M., Brambilla, C., Holmes, C. Y. & Staley, H. (1998). Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis. International Journal of Clinical Practice52, 289\u201397.","DOI":"10.1111\/j.1742-1241.1998.tb11633.x"},{"key":"key\n\t\t\t\t20170411034535_R35","doi-asserted-by":"crossref","unstructured":"Monso, E., Ruiz, J., Rosell, A., Manterola, J., Fiz, J., Morera, J. et al. (1995). Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. American Journal of Respiratory Critical Care Medicine152 , 1316\u201320.","DOI":"10.1164\/ajrccm.152.4.7551388"},{"key":"key\n\t\t\t\t20170411034535_R36","doi-asserted-by":"crossref","unstructured":"Rutman, A., Dowling, R., Wills, P., Feldman, C., Cole, P. J. & Wilson, R. (1998). Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. Antimicrobial Agents and Chemotherapy42, 772\u20138.","DOI":"10.1128\/AAC.42.4.772"},{"key":"key\n\t\t\t\t20170411034535_R37","doi-asserted-by":"crossref","unstructured":"Ferguson, J. (1995). Fluoroquinolone photosensitization: a review of clinical and laboratory studies. Photochemistry and Photobiology62, 954\u20138.","DOI":"10.1111\/j.1751-1097.1995.tb02392.x"},{"key":"key\n\t\t\t\t20170411034535_R38","unstructured":"Ferguson, J., Al-Ajmi, H., Kubin, R., Daggett, S. & Saggu, P. S. (1998). A double-blind, placebo and lomefloxacin controlled human volunteer study to determine the photosensitising potential of oral moxifloxacin (BAY 12-8039). In Program and Abstracts of the Eighth International Congress on Infectious Diseases, Boston, USA, 1998. Abstract 59.001, p. 197. International Society for Infectious Diseases."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/4\/501\/13057273\/JAC444501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T23:43:38Z","timestamp":1704411818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.4.501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1999,10]]},"published-print":{"date-parts":[[1999,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.4.501","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}